AI Summary
✦ ClarthaValuation Metrics
Trading 36.9% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.35). Confidence: 76%.
Live forward EPS implies next-12-month EPS of ₹10.60. Applying the stock's normalized valuation corridor produces a fair range of ₹287.68 to ₹448.06, with base value near ₹345.45 (+19.5% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹10.60
Forward P/E
27.3x
Base Fair Value
₹345.45
Fair Range
₹287.68 - ₹448.06
Upside To Base
+19.5%
Estimate Source
Live forward EPS
Growth Estimate
+20.6%
5Y Average
36.96
Current
44.62
Overvalued
42.27
Undervalued
27.14
5Y Average
21.02
Current
25.11
Overvalued
25.18
Undervalued
16.70
5Y Average
5.95
Current
7.11
Overvalued
7.13
Undervalued
4.73
Peers & Comparison
Sector: Health Care · Theme: Hospitals & Diagnostic Centres
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
RAINBOW CHILDRENS MED LTD RAINBOWHospitals & Diagnostic Centres | +33.2% | 15.7% | 54.4x Undervalued | -26% vs avg | +1.2% |
METROPOLIS HEALTHCARE LTD METROPOLISHospitals & Diagnostic Centres | +16.6% | 11.8% | 58.9x Undervalued | -20% vs avg | +7.6% |
JUPITER LIFE LINE HOSP L JLHLHospitals & Diagnostic Centres | +18.2% | 12.0% | 55.6x Undervalued | -24% vs avg | +12.9% |
THYROCARE TECH LTD THYROCAREHospitals & Diagnostic Centres | +24.3% | 20.1% | 54.7x Undervalued | -25% vs avg | +38.2% |
NARAYANA HRUDAYALAYA LTD. NHHospitals & Diagnostic Centres | +80.4% | 9.0% | 45.4x Undervalued | -38% vs avg | +6.8% |
NEPHROCARE HEALTH SERV L NEPHROPLUSHospitals & Diagnostic Centres | +21.2% | 7.7% | 86.7x Premium | +18% vs avg | +48.1% |
GLOBAL HEALTH LIMITED MEDANTAHospitals & Diagnostic Centres | +26.5% | 11.9% | 71.4x Fair | -3% vs avg | +6.9% |
KRISHNA INST OF MED SCI L KIMSHospitals & Diagnostic Centres | +35.3% | 4.8% | 159.9x Premium | +118% vs avg | +10.2% |
PARK MEDI WORLD LIMITED trades at a discount (45.8x vs peer avg 73.4x), suggesting potential undervaluation relative to the Hospitals & Diagnostic Centres cohort. Peers include RAINBOW CHILDRENS MED LTD, METROPOLIS HEALTHCARE LTD, JUPITER LIFE LINE HOSP L — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.